GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Double Bond Pharmaceutical International AB (XSAT:DBP B) » Definitions » Shiller PE Ratio

Double Bond Pharmaceutical International AB (XSAT:DBP B) Shiller PE Ratio : (As of Jul. 16, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Double Bond Pharmaceutical International AB Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Double Bond Pharmaceutical International AB Shiller PE Ratio Historical Data

The historical data trend for Double Bond Pharmaceutical International AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Double Bond Pharmaceutical International AB Shiller PE Ratio Chart

Double Bond Pharmaceutical International AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Double Bond Pharmaceutical International AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Double Bond Pharmaceutical International AB's Shiller PE Ratio

For the Biotechnology subindustry, Double Bond Pharmaceutical International AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Double Bond Pharmaceutical International AB's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Double Bond Pharmaceutical International AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Double Bond Pharmaceutical International AB's Shiller PE Ratio falls into.


;
;

Double Bond Pharmaceutical International AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Double Bond Pharmaceutical International AB's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Double Bond Pharmaceutical International AB's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.01/132.8245*132.8245
=-0.010

Current CPI (Mar. 2025) = 132.8245.

Double Bond Pharmaceutical International AB Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 -0.061 99.995 -0.081
201509 -0.121 100.228 -0.160
201512 0.000 100.276 0.000
201603 -0.091 100.751 -0.120
201606 -0.136 101.019 -0.179
201609 -0.114 101.138 -0.150
201612 0.230 102.022 0.299
201703 -0.136 102.022 -0.177
201706 -0.151 102.752 -0.195
201709 -0.121 103.279 -0.156
201712 -0.141 103.793 -0.180
201803 -0.129 103.962 -0.165
201806 -0.106 104.875 -0.134
201809 -0.076 105.679 -0.096
201812 -0.071 105.912 -0.089
201903 -0.066 105.886 -0.083
201906 -0.082 106.742 -0.102
201909 -0.066 107.214 -0.082
201912 -0.041 107.766 -0.051
202003 -0.107 106.563 -0.133
202006 -0.067 107.498 -0.083
202009 -0.100 107.635 -0.123
202012 -0.107 108.296 -0.131
202103 -0.100 108.360 -0.123
202106 -0.092 108.928 -0.112
202109 -0.059 110.338 -0.071
202112 0.090 112.486 0.106
202203 -0.059 114.825 -0.068
202206 -0.040 118.384 -0.045
202209 -0.040 122.296 -0.043
202212 -0.080 126.365 -0.084
202303 -0.060 127.042 -0.063
202306 -0.040 129.407 -0.041
202309 -0.020 130.224 -0.020
202312 -0.080 131.912 -0.081
202403 -0.030 132.205 -0.030
202406 -0.050 132.716 -0.050
202409 -0.010 132.304 -0.010
202412 -0.050 132.987 -0.050
202503 -0.010 132.825 -0.010

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Double Bond Pharmaceutical International AB  (XSAT:DBP B) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Double Bond Pharmaceutical International AB Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Double Bond Pharmaceutical International AB's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Double Bond Pharmaceutical International AB Business Description

Traded in Other Exchanges
N/A
Address
Virdings Alle 32B, Uppsala, SWE, 75450
Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.

Double Bond Pharmaceutical International AB Headlines

No Headlines